Lifeward Ltd. announced on January 8, 2025, the closing of its previously announced registered direct offering. The offering resulted in gross proceeds of approximately $5.0 million for the company, before deducting placement agent fees and other offering expenses.
The offering included the issuance and sale of 1,818,183 ordinary shares at a purchase price of $2.75 per share. Additionally, unregistered short-term warrants to purchase up to 1,818,183 ordinary shares were issued in a concurrent private placement.
The net proceeds from this financing are designated for continuing commercial efforts, working capital, and general corporate purposes. This capital infusion supports Lifeward's ongoing operations and strategic initiatives.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.